PlumeStars participates at Lifebility Award 2022 - PlumeStars

Skip to content

Who We Are
Our Products
Products
Our Products

THALIDOMIDE (TALDO)

CISPLATIN (HYALCIS)

AMIKACIN (AMIKA PS)

TOBRAMYCIN (TOBRA PS)
THALIDOMIDE
EMA Public Summary of opinion on orphan designation for Thalidomide

EMA summary report for Thalidomide

EMA Opinion of the Commitee for Orphan Medicinal Products on orphan medicinal product desigantion For Thalidomide
CISPLATIN
EMA Public Summary of opinion on orphan designation for Cisplatin

EMA summary report for Cisplatin

EMA Opinion of the Commitee for Orphan Medicinal Products on orphan medicinal product desigantion For Cispaltin
AMIKACIN
EMA Public Summary of opinion on orphan designation for Amikacin

Plumestars’s Scientific Pubblications
Our Video
News
- News
- Events
- Awards
- Press
- Government Grants
- About Us
Plumestars Activities
Ethics
Contact Us

PlumeStars participates at Lifebility Award 2022

PlumeStars is among the finalists for Lifebility Award 2022.

Copyright © PlumeStars s.r.l.

Viale Parco Area delle Scienze 27/A
43124 Parma (PR), Italy
P.IVA C.F. 02698350341

Archivio

Archivio

Meta

Accedi
Feed dei contenuti
Feed dei commenti
WordPress.org